Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
Authors
Keywords
-
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-12
DOI
10.1186/s12885-018-5010-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells
- (2017) Luchun Li et al. Oncology Letters
- The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer
- (2017) Shingo Tayama et al. Oncotarget
- EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance
- (2016) Xiaohu Zheng et al. CANCER RESEARCH
- Circulating tumour cells as biomarkers of prostate, bladder and kidney cancer
- (2016) Michael A. Gorin et al. Nature Reviews Urology
- Monitoring Prostate Tumor Growth in an Orthotopic Mouse Model Using Three-Dimensional Ultrasound Imaging Technique
- (2016) Jie Ni et al. Translational Oncology
- Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- (2015) Zhenling Deng et al. BMC IMMUNOLOGY
- Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
- (2015) Lei Chang et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
- (2014) P Massoner et al. BRITISH JOURNAL OF CANCER
- Cancer Stem Cells in Prostate Cancer Chemoresistance
- (2014) Jie Ni et al. CURRENT CANCER DRUG TARGETS
- Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy
- (2014) Naoya Murakami et al. LARYNGOSCOPE
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- EpCAM: Structure and function in health and disease
- (2013) Ulrike Schnell et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
- (2013) Jie Ni et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205
- (2012) Martin Puhr et al. AMERICAN JOURNAL OF PATHOLOGY
- Role of the EpCAM (CD326) in prostate cancer metastasis and progression
- (2012) Jie Ni et al. CANCER AND METASTASIS REVIEWS
- Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
- (2012) D. J. Mulholland et al. CANCER RESEARCH
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma
- (2012) Gerhard Moldenhauer et al. JNCI-Journal of the National Cancer Institute
- EpCAM regulates cell cycle progression via control of cyclin D1 expression
- (2012) A Chaves-Pérez et al. ONCOGENE
- In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147
- (2012) Jingli Hao et al. PLoS One
- Current and emerging treatment modalities for metastatic castration-resistant prostate cancer
- (2011) Sergio Bracarda et al. BJU INTERNATIONAL
- Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity
- (2011) Kaori Imadome et al. CANCER BIOLOGY & THERAPY
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- New and emerging agents for the treatment of castration-resistant prostate cancer
- (2011) Celestia S. Higano et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer
- (2011) Goran Benko et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- PI3K, Erk Signaling in BMP7-Induced Epithelial-Mesenchymal Transition (EMT) of PC-3 Prostate Cancer Cells in 2- and 3-Dimensional Cultures
- (2011) Minyoung Lim et al. Hormones & Cancer
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside
- (2010) Jean-Emmanuel Kurtz et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models By 213Bilabeled Multiple Targeted Radioimmunoconjugates
- (2009) Y. Li et al. CLINICAL CANCER RESEARCH
- Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
- (2009) Alexei V. Salnikov et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started